A citation-based method for searching scientific literature

Omidvar Rezaei, Kasra Honarmand Tamizkar, Mohammadreza Hajiesmaeili, Mohammad Taheri, Soudeh Ghafouri-Fard. Front Oncol 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity





LncRNA DLX6-AS1 Promotes the Progression of Neuroblastoma by Activating STAT2 via Targeting miR-506-3p.
Yanping Hu, Huifang Sun, Jiting Hu, Xiaomin Zhang. Cancer Manag Res 2020
7
100

Post-translational Control of RNA-Binding Proteins and Disease-Related Dysregulation.
Alejandro Velázquez-Cruz, Blanca Baños-Jaime, Antonio Díaz-Quintana, Miguel A De la Rosa, Irene Díaz-Moreno. Front Mol Biosci 2021
5
100

HOXA9 Expression is Associated with Advanced Tumour Stage and Prognosis in Nasopharyngeal Carcinoma.
Tiancong Liu, Chao Ji, Yang Sun, Weiliang Bai. Cancer Manag Res 2021
1
100

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
100

Long non‑coding RNA DLX6‑AS1 is associated with malignant progression and promotes proliferation and invasion in esophageal squamous cell carcinoma.
Mingchen Wang, Yuan Li, Yixin Yang, Xiaosa Liu, Mingxi Zang, Yuebai Li, Kunpeng Yang, Wanguang Yang, Shanfeng Zhang. Mol Med Rep 2019
11
100


The emerging role of Snail1 in the tumor stroma.
A Herrera, M Herrera, C Peña. Clin Transl Oncol 2016
13
100


Cancer drug resistance induced by EMT: novel therapeutic strategies.
Javier De Las Rivas, Anamaria Brozovic, Sivan Izraely, Alba Casas-Pais, Isaac P Witz, Angélica Figueroa. Arch Toxicol 2021
7
100



LncRNA DLX6-AS1/miR-129-5p/DLK1 axis aggravates stemness of osteosarcoma through Wnt signaling.
Rong-Mou Zhang, Ting Tang, Hai-Ming Yu, Xue-Dong Yao. Biochem Biophys Res Commun 2018
38
100

Emerging ways to treat breast cancer: will promises be met?
Pouria Samadi, Sahar Saki, Fatemeh Karimi Dermani, Mona Pourjafar, Massoud Saidijam. Cell Oncol (Dordr) 2018
27
100



Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway.
Hengbing Wang, Xiaobing Niu, Hesong Jiang, Fei Mao, Bing Zhong, Xi Jiang, Guangbo Fu. Aging (Albany NY) 2020
12
100

OCT1 is a determinant of synbindin-related ERK signalling with independent prognostic significance in gastric cancer.
Jin Qian, Xuan Kong, Niantao Deng, Patrick Tan, Haoyan Chen, Jilin Wang, Zhaoli Li, Ye Hu, Weiping Zou, Jie Xu,[...]. Gut 2015
47
100

LncRNA DLX6-AS1 promotes laryngeal squamous cell carcinoma growth and invasion through regulating miR-376c.
Qingjun Yang, Jin Sun, Yifei Ma, Chunjie Zhao, Jijun Song. Am J Transl Res 2019
11
100


Long noncoding RNA DLX6-AS1 promotes breast cancer progression via miR-505-3p/RUNX2 axis.
Ping Zhao, Haitao Guan, Zhijun Dai, Yuguang Ma, Yang Zhao, Di Liu. Eur J Pharmacol 2019
21
100


Exosomal long non-coding RNA DLX6-AS1 as a potential diagnostic biomarker for non-small cell lung cancer.
Xilin Zhang, Huihui Guo, Ying Bao, Huanming Yu, Dong Xie, Xiang Wang. Oncol Lett 2019
19
100


The lncRNA DLX6-AS1 promoted cell proliferation, invasion, migration and epithelial-to-mesenchymal transition in bladder cancer via modulating Wnt/β-catenin signaling pathway.
Jinan Guo, Zhixin Chen, Hongtao Jiang, Zhou Yu, Junming Peng, Jing Xie, ZaiShang Li, Weiqing Wu, Zhiqiang Cheng, Kefeng Xiao. Cancer Cell Int 2019
20
100

DNA Methyltransferases in Cancer: Biology, Paradox, Aberrations, and Targeted Therapy.
Jiayu Zhang, Cheng Yang, Chunfu Wu, Wei Cui, Lihui Wang. Cancers (Basel) 2020
25
100



Targeting the crosstalk between canonical Wnt/β-catenin and inflammatory signaling cascades: A novel strategy for cancer prevention and therapy.
Devesh Tewari, Sweta Bawari, Shikha Sharma, Lindsay K DeLiberto, Anupam Bishayee. Pharmacol Ther 2021
7
100

How the Warburg effect supports aggressiveness and drug resistance of cancer cells?
Philippe Icard, Seth Shulman, Diana Farhat, Jean-Marc Steyaert, Marco Alifano, Hubert Lincet. Drug Resist Updat 2018
128
100


Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and Lipogenesis.
Colin A Flaveny, Kristine Griffett, Bahaa El-Dien M El-Gendy, Melissa Kazantzis, Monideepa Sengupta, Antonio L Amelio, Arindam Chatterjee, John Walker, Laura A Solt, Theodore M Kamenecka,[...]. Cancer Cell 2015
101
100

Serum Exosomal lncRNA DLX6-AS1 Is a Promising Biomarker for Prognosis Prediction of Cervical Cancer.
Xian-Zhen Ding, Shi-Qiang Zhang, Xiao-Lan Deng, Jin-Hu Qiang. Technol Cancer Res Treat 2021
6
100

Long noncoding RNA DLX6-AS1 promotes neuroblastoma progression by regulating miR-107/BDNF pathway.
Huan-Yu Zhang, Mao-Qing Xing, Jing Guo, Jin-Chuan Zhao, Xin Chen, Zhong Jiang, Hong Zhang, Qian Dong. Cancer Cell Int 2019
16
100


LncRNA DLX6-AS1 promoted cancer cell proliferation and invasion by attenuating the endogenous function of miR-181b in pancreatic cancer.
Yong An, Xue-Min Chen, Yong Yang, Feng Mo, Yong Jiang, Dong-Lin Sun, Hui-Hua Cai. Cancer Cell Int 2018
29
100

Breast cancer.
Sibylle Loibl, Philip Poortmans, Monica Morrow, Carsten Denkert, Giuseppe Curigliano. Lancet 2021
33
100

Expression of long non-coding RNA DLX6-AS1 in lung adenocarcinoma.
Juan Li, Ping Li, Wei Zhao, Rui Yang, Shanshan Chen, Yong Bai, Shaozhi Dun, Xiaonan Chen, Yuwen Du, Yuanyuan Wang,[...]. Cancer Cell Int 2015
58
100

Current development of CBP/p300 inhibitors in the last decade.
Zhang-Xu He, Bing-Fei Wei, Xin Zhang, Yun-Peng Gong, Li-Ying Ma, Wen Zhao. Eur J Med Chem 2021
17
100

The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
J-J Zhang, W-R Xu, B Chen, Y-Y Wang, N Yang, L-J Wang, Y-L Zhang. Eur Rev Med Pharmacol Sci 2019
19
100

Silencing of long non-coding RNA DLX6-AS1 weakens neuroblastoma progression by the miR-513c-5p/PLK4 axis.
Peisheng Jia, Erhu Wei, Huiqiong Liu, Tingting Wu, Huaili Wang. IUBMB Life 2020
3
100

Long non-coding RNA DLX6-AS1 aggravates hepatocellular carcinoma carcinogenesis by modulating miR-203a/MMP-2 pathway.
Lei Zhang, Xiaowei He, Ting Jin, Li Gang, Zhenlin Jin. Biomed Pharmacother 2017
53
100

DLX6 Antisense RNA 1 Modulates Glucose Metabolism and Cell Growth in Gastric Cancer by Targeting microRNA-4290.
Yan Qian, Wei Song, Xu Wu, Guowei Hou, Haixiao Wang, Xiao Hang, Tianfang Xia. Dig Dis Sci 2021
8
100



Translational remodeling by RNA-binding proteins and noncoding RNAs.
J J David Ho, Jeffrey H S Man, Jonathan H Schatz, Philip A Marsden. Wiley Interdiscip Rev RNA 2021
5
100


Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells.
Dong-Mei Wu, Zi-Hui Zheng, Ying-Bo Zhang, Shao-Hua Fan, Zi-Feng Zhang, Yong-Jian Wang, Yuan-Lin Zheng, Jun Lu. J Exp Clin Cancer Res 2019
44
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.